SCHEMBL20175929

SCHEMBL20175929

CCN(CCN(CC)Cc1cc(C)ccc1O)Cc1cc(C)ccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.53
POLB P06746 4/20 0.52
MAPT P10636 4/20 0.52
ALDH1A1 P00352 4/20 0.52
TDP1 Q9NUW8 2/20 0.52
HTT P42858 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
APEX1 P27695 1/20 0.52
MAPK1 P28482 1/20 0.52
RECQL P46063 1/20 0.52
CACNA1B Q00975 1/20 0.52
APBA1 Q02410 1/20 0.52
KMT2A Q03164 1/20 0.52
MCL1 Q07820 1/20 0.52
HKDC1 Q2TB90 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ACHE P22303 2/20 0.51
JAK2 O60674 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15383500 0.93 PRKCI (0.56) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL6266901 0.88 POLB (0.67) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL23080065 0.84 TAAR1 (0.50) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL20175930 0.83 POLB (0.55) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL15383502 0.81 AMY1A (0.61) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL6914086 0.76 MAPT (0.46) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL545256 0.75 HTT (0.48) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL8056096 0.75 TAAR1 (0.55) POLBMAPTALDH1A1TDP1KDM4E
SCHEMBL935095 0.74 HTT (0.47) PRKCIPOLBMAPTALDH1A1TDP1
SCHEMBL935126 0.74 HTT (0.47) PRKCIPOLBMAPTALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180140581-A1 METABOLICALLY PROGRAMMED METAL CHELATORS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140581-A1 METABOLICALLY PROGRAMMED METAL CHELATORS AND USES THEREOF FECH, SLC19A1, SLC40A1 PRKCI 4004/4885POLB 2257/4885MAPT 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.